D. Caporossi et al., HYPERSENSITIVITY OF LYMPHOBLASTOID LINES DERIVED FROM ATAXIA-TELANGIECTASIA PATIENTS TO THE INDUCTION OF CHROMOSOMAL-ABERRATIONS BY ETOPOSIDE (VP-16), MUTATION RESEARCH, 290(2), 1993, pp. 265-272
Mammalian DNA topoisomerase II represents the cellular target of many
antitumor drugs, such as epipodophyllotoxin VP-16 (etoposide). The mec
hanism by which VP-16 exerts its cytotoxic and antineoplastic actions
has not yet been firmly established, although the unique correlation b
etween sensitivity to ionizing radiation and to topoisomerase II inhib
itors suggest the involvement of DNA double-strand breaks. In the pres
ent study we analyzed the chromosomal sensitivity of lymphoblastoid ce
ll lines derived from ataxia telangiectasia (AT) patients to low conce
ntrations of the drug. Our results indicate that AT derived cells are
hypersensitive to the clastogenic activity of VP-16 either when the dr
ug is present for the whole duration of the cell cycle or specifically
in the G2 phase, confirming that the induction of DNA double strand b
reaks, to which AT cells seem typically sensitive, could have an impor
tant role in the biological activity of VP-16.